Find your Lumoral reseller Find your Lumoral reseller here.
Home / News

News

Experience Scientifically Sound Dental Care: Test your inflammation status at the Lumoral booth at FIBO 2024

Experience Scientifically Sound Dental Care: Test your inflammation status at the Lumoral booth at FIBO 2024

If you want to improve your athletic performance, there are many things you can do. Contrary to popular belief, maintaining optimal oral health can significantly impact athletic performance, as confirmed by recent scientific studies.

Recent research has highlighted the close connection between gum inflammation (gingivitis/periodontitis) and athletic performance. According to leading experts, severity of inflammation directly correlates with decreased performance in activities such as weightlifting and fitness tests. 

Gingivitis, characterized by inflammation of the gums due to plaque buildup, and periodontitis, a more severe condition affecting both the gums and the supporting jawbone, are prevalent oral health issues. Left untreated, these conditions can lead to tooth loss and other serious complications. 

To address this critical issue, Finnish scientists have developed a revolutionary solution designed to combat plaque and inflammation effectively. Lumoral utilizes innovative light-activated technology, scientifically proven in numerous studies, to target and eliminate harmful oral bacteria, which is associated with 95 % of all oral diseases. 

Annimari is one of the fastest Finnish 100-meter hurdle runners ever. Since adding antibacterial light-activated treatment to her oral hygiene routine, Annimari has noticed a significant improvement in her gum health. 

Test your inflammation status! 

Attendees of the FIBO event, taking place at the Exhibition Centre Cologne, Germany, from April 11th to 14th, will have the exclusive opportunity to test their inflammation status at the Lumoral booth (Hall 5.2 Stand B 42). Through a quick and simple test, participants can determine whether inflammatory processes are occurring in their mouths, providing valuable insights into their oral health status. The test, worth € 60, is free of charge at the FIBO event.

Furthermore, attendees can learn more about the future of oral care. Lumoral offers targeted inflammation control, enabling athletes and individuals alike to maintain optimal oral health and enhance their performance. By incorporating Lumoral into their dental care routine, professionals, recreational and age group athletes can prevent tooth and gum disease, paving the way for improved athletic performance and overall well-being. 

- We are excited to unveil Lumoral's groundbreaking research at FIBO, highlighting the profound impact of oral health on athletic performance, said Sakari Nikinmaa, CEO at Koite Health Ltd.  

Don't miss the opportunity to discover the future of dental care and its implications for athletic performance at FIBO. Visit the Lumoral booth to learn more about this innovative solution and take the first step towards a healthier, more successful lifestyle. You can also attend the two lectures on this topic, one on Saturday at 10:00 and the other on Sunday at 16:40. The lectures will take place in the Nutrition & Diagnostics Area in Hall 4.2.

For more information about Lumoral, please visit www.zeroplaque.de OR www.lumoralpro.com.

Periodontitis and Diabetes: The Connection Between Two Common Diseases

Periodontitis and Diabetes: The Connection Between Two Common Diseases

Periodontitis and diabetes are two prevalent diseases with a strong bidirectional relationship between them. Poorly managed diabetes promotes the progression of periodontitis and complicates its treatment. Conversely, active periodontitis adversely affects diabetes management and treatment.

In honor of World Health Day, Tommi Pätilä, a heart and transplant surgeon at HUS New Children's Hospital, in Finland, and Timo Sorsa, a professor of oral and maxillofacial diseases at the University of Helsinki, reflect on the connection between these two prevalent diseases from the perspective of oral health.

Diabetes and gum inflammation are two significant global health issues that require immediate attention. About half of the world's population suffers from gum inflammation, while nearly half a billion people have diabetes.

In Finland alone, there are approximately 500,000 diabetics, with about 50,000 suffering from type 1 diabetes and around 400,000 from type 2 diabetes. Additionally, it is estimated that there are up to 100,000 undiagnosed type 2 diabetics in Finland.

Understanding the Close Connection

Periodontitis is a disease of the tooth-supporting tissues that progresses from gum inflammation and can ultimately lead to tooth loss. Symptoms of the disease include red, swollen, and bleeding gums, gum recession, formation of gum pockets, loosening of teeth, bad breath, and possible swallowing and chewing problems.

Periodontitis is associated with many risk factors, such as smoking, genetic factors, and systemic diseases like diabetes.

The symptoms of the disease can vary from mild to severe and often require evaluation and treatment by a dentist or dental hygienist. Early detection and treatment are crucial for managing periodontitis.

Diabetic patients have an increased risk of developing periodontitis, and conversely, periodontitis has a negative impact on diabetes treatment and management. High blood sugar levels increase inflammation in the mouth and hinder the healing of periodontitis. The combined effect of these two diseases is also reflected in systemic inflammatory markers and blood sugar levels.

Traditional diagnostic methods are not always sufficient to identify the risk of periodontitis and diabetes. Therefore, new biomarker-based rapid tests have been developed to help identify the risk of these diseases at an early stage.

Oral Health Status Revealed in Minutes

The aMMP-8 rapid test developed in Finland is based on measuring the concentration of active matrix metalloproteinase 8 (aMMP-8) in mouthwash. Studies have shown that elevated levels of aMMP-8 may indicate both periodontitis and diabetes.

The aMMP-8 rapid test can be performed at the dentist's office, and the results are obtained immediately. This allows for early intervention in the development of periodontitis and assessment of the risk of diabetes. Additionally, the test provides patients with important information about their oral health and the risk of diabetes, which encourages better self-care and adherence to healthy lifestyles.

"The test allows for the detection of signs of periodontitis even before symptoms occur, which provides an opportunity for early treatment and prevention of complications," says Professor Timo Sorsa of the University of Helsinki's Department of Oral and Maxillofacial Diseases.

The test has proven to be useful in screening patients with type I, type II, and gestational diabetes.

Oral Health: A Crucial Factor for Diabetics

Diabetic patients with periodontitis require special attention, reminds pediatric heart and transplant surgeon Tommi Pätilä. Pätilä is also one of the developers of the Lumoral innovation, which enhances mechanical oral hygiene.

"It is especially important for diabetics to invest in regular oral hygiene and dental visits. This not only improves patients' quality of life but also reduces the risk of long-term complications," says Pätilä.

According to Pätilä, adjunctive therapies can be combined with at-home oral hygiene management, such as low-dose doxycycline acting as an aMMP-8 inhibitor and light-activated mouthwashes with anti-inflammatory effects.

"Antibacterial Lumoral treatment effectively removes harmful plaque bacteria from tooth surfaces and gum lines. Home-administered Lumoral treatment has been shown to be significantly more effective and better tolerated than chlorhexidine-based mouthwashes commonly used today," Pätilä explains.

Pätilä emphasizes that antibacterial treatment complements mechanical tooth cleaning and does not replace the need for brushing and cleaning between teeth. Why is additional treatment needed to enhance mechanical oral cleaning?

"Research shows that brushing only removes 65% of plaque. Residual plaque remains in the mouth even after the most effective brushing. Lumoral helps remove this residual plaque. Regular Lumoral treatment ensures that tooth surfaces are thoroughly clean. Diabetics, in particular, benefit from this removal of residual plaque," says Pätilä.

According to studies, regular adjunctive antibacterial treatment alongside traditional non-surgical standard treatment reduces inflammation in gum tissues and improves oral hygiene and healing of deep pockets in chronic periodontitis compared to conventional treatment.

Antibacterial treatment has also been shown to prevent and improve inflammation of peri-implant tissues. The treatment is suitable for everyone, but light-activated antibacterial treatment is seen as most effective for patients who require enhanced oral hygiene.

***

World Health Day, launched by the World Health Organization (WHO), is celebrated globally on April 7th to increase awareness of health issues. This year, the timely theme "My health, my right" emphasizes the importance of health equity.

*** 

References:

Trujillo K, Räisänen IT, Sorsa T, Pätilä T. Repeated daily use of dual-light antibacterial photodynamic therapy in periodontal disease—a case report. Dent J (Basel). 2022;10(9):163. doi:10.3390/dj10090163

Pakarinen S, Saarela RKT, Välimaa H, et al. Home-applied dual-light photodynamic therapy in the treatment of stable chronic periodontitis (HOPE-CP)—three-month interim results. Dent J (Basel). 2022;10(11):206. doi:10.3390/dj10110206

Gholami L, Shahabi S, Jazaeri M, Hadilou M, Fekrazad R. Clinical applications of antimicrobial photodynamic therapy in dentistry. Front Microbiol. 2023;13:1020995. doi:10.3389/fmicb.2022.1020995

Lähteenmäki H, Pätilä T, Räisänen I, Kankuri E, Tervahartiala T, Sorsa T. Repeated Home-Applied Dual-Light Antibacterial Photodynamic Therapy Can Reduce Plaque Burden, Inflammation, and aMMP-8 in Peri-Implant Disease – A Pilot Study. Curr Issues Mol Biol 2022; 44: 1273–1283. doi: 10.3390/cimb44030085

Koite Health Collaborates with Innodent Trading: Revolutionizing Dental Care in Thailand with its Lumoral Technology

Koite Health Collaborates with Innodent Trading: Revolutionizing Dental Care in Thailand with its Lumoral Technology

In the field of dental care, changes are constant as fresh ideas shape the industry. A recent collaboration agreement between Finland’s Koite Health Ltd and Trading Co., Ltd. from Thailand is set to revolutionize dental care standards by introducing innovative light-activated technology to the country.

Founded in 2017, Innodent has been at the forefront of delivering cutting-edge dental solutions to Thailand's healthcare sector. Driven by a commitment to leverage the latest advancements in high-tech solutions, the company aims to provide the most innovative technologies to the dental industry. This strategic vision led to a partnership with Koite Health, and the introduction of Lumoral, a Finnish med-tech innovation, to the dental market in Thailand.

– The introduction of Lumoral to Innodent's product portfolio was the result of a personal recommendation from Dr. Hildebrand, a renowned maxillofacial surgeon from Berlin. Dr. Hildebrand's successful clinical experiences with Lumoral convinced the team at Innodent to explore this revolutionary technology further, explains Thomas Constantin, CEO and owner of Innodent Trading Co., Ltd.

Lumoral: an innovative personal healthcare device

So, what exactly is Lumoral, and how does it work? Mr. Constantin reminds that the close link between oral bacteria and overall health and well-being is an important factor that sparked interest in the Finnish oral health-enhancing innovation in the first place.

– Oral bacteria can cause dental caries and bad breath but there can also be more severe secondary effects such as cardiovascular diseases, dementia, psoriasis and many more. Overall health starts with a healthy mouth. It is therefore important to regularly clean the mouth thoroughly.

Lumoral is an innovative personal healthcare device designed to remove 99.9% of harmful oral bacteria while preserving the healthy mouth flora. Traditional oral hygiene methods can only remove approximately 60% of bacteria, leaving behind a significant risk of oral health issues, Thomas explains.

Lumoral's advanced technology utilizes color molecules in its Lumorinse mouth rinse, which adhere to harmful oral bacteria attached to teeth surfaces and gum tissue in the mouth. Subsequently, the light emitted by the mouthpiece reacts with the green sensitizer, effectively breaking down the cell membrane of bacteria and destroying them both from inside and outside. This method ensures the eradication of harmful bacteria without the risk of resistance development.

Long-term benefits for implant patients

The addition of Lumoral to Innodent's product portfolio aligns with the company’s focus on dental implantology, with a specialization in ceramic implants. While the industry predominantly utilizes titanium implants, scientific evidence suggests a significant risk of peri-implantitis, an inflammation of the tissues surrounding these metal implants, over time.

– Lumoral presents a solution to mitigate this risk, offering long-term benefits for implant patients, Constantin says.

Furthermore, Lumoral's versatility extends beyond implant care, offering benefits for individuals with various oral health concerns, including chronic bad breath, gum disease, and orthodontic patients wearing braces or clear aligners.

– This accessibility makes Lumoral an invaluable addition to Innodent's offerings, catering to a diverse range of dental needs in Thailand.

– The great advantage of Lumoral however, is that everyone benefits from removing harmful oral bacteria. Whether you are wearing braces or clear aligners, suffer from chronic bad breath, gum disease or simply want to have a perfectly clean and healthy mouth, Lumoral is your solution.

Promising prospects for both companies

The collaboration between Koite Health and Innodent holds promising prospects for both companies and dental patients in Thailand. Mr. Constantin says that for Innodent, this partnership marks a significant expansion into the business-to-consumer (B2C) market, enabling the company to reach individual consumers through online channels like their dedicated webshop.

– This shift opens new avenues for marketing and sales, enhancing accessibility to innovative dental solutions for patients across the country. Ultimately, the collaboration aims to raise awareness about oral health and its crucial role in overall well-being among the Thai population.

– By introducing Lumoral's advanced technology to the market, Koite Health and Innodent are paving the way for a new era of dental care in Thailand, one that prioritizes prevention, innovation, and improved patient outcomes.